See the Slides & Recording – Update on Risperdal Mass Tort Litigation with Robert Mosier Posted on September 9, 2015 by Larry Bodine Risperdal is a very powerful antipsychotic developed by Janssen Pharmaceuticals to treat schizophrenia in adults. However Janssen illegally marketed and sold it to one of the most vulnerable segments of our society – our children – and hid a disfiguring side effect that caused a generation of young boys and men to grow female breasts. Attorney Mosier discusses cases pending in Philadelphia, Los Angeles and St. Louis, and rulings by the courts in those jurisdictions. More than 5,000 cases have been filed across the country, which may be the tip of the spear, because hundreds of thousands of young boys took Risperdal and suffered gynecomastia. https://thenationaltriallawyers.org/wp-content/uploads/2015/09/2015-09-09-10.03-An-Update-on-Risperdal-Litigation.mp4 Robert Mosier Questions? Contact Robert Mosier Sanders Phillips Grossman, LLC 2860 Michelle Drive, Ste 220 Irvine, CA 92606 [email protected] 949-233-7002 Cell About our presenter Robert A. Mosier is a trial lawyer with the law firm of Sanders Phillips Grossman, LLP in Irvine, California. Mr. Mosier’s practice is focused on representing plaintiffs harmed by pharmaceutical and medical device companies. He also maintains an active medical malpractice caseload. He serves as Plaintiff’s Co-Lead Counsel in the Risperdal and Invega Product Liability Cases JCCP 4775. Mr. Mosier is an AV Preeminent Attorney, a member of the Million Dollar Advocates Forum, an Arizona Top Rated Attorney – Top Trial Lawyers in America and National Trial Lawyers – Top 100.
